C12Y 301/01
Carboxylic ester hydrolases
Official title: Carboxylic ester hydrolases (3.1.1)
C12Y301/01 (Carboxylic ester hydrolases) appears on 1,014 US grants and 1,671 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1,014
- Published applications
- 1,671
- Assignees
- 752
- Inventors
- 3,642
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 5 | 0 |
| 1989 | 3 | 0 |
| 1990 | 4 | 0 |
| 1991 | 4 | 0 |
| 1992 | 3 | 0 |
| 1993 | 3 | 0 |
| 1994 | 3 | 0 |
| 1995 | 10 | 0 |
| 1996 | 6 | 0 |
| 1997 | 8 | 0 |
| 1998 | 8 | 0 |
| 1999 | 15 | 0 |
| 2000 | 11 | 0 |
| 2001 | 13 | 2 |
| 2002 | 16 | 21 |
| 2003 | 10 | 36 |
| 2004 | 12 | 27 |
| 2005 | 9 | 20 |
| 2006 | 12 | 22 |
| 2007 | 5 | 33 |
| 2008 | 11 | 29 |
| 2009 | 9 | 35 |
| 2010 | 16 | 39 |
| 2011 | 30 | 60 |
| 2012 | 36 | 59 |
| 2013 | 56 | 61 |
| 2014 | 33 | 55 |
| 2015 | 38 | 90 |
| 2016 | 53 | 95 |
| 2017 | 48 | 103 |
| 2018 | 57 | 64 |
| 2019 | 67 | 104 |
| 2020 | 65 | 89 |
| 2021 | 77 | 102 |
| 2022 | 50 | 101 |
| 2023 | 42 | 83 |
| 2024 | 71 | 142 |
| 2025 | 59 | 103 |
| 2026 | 32 | 96 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 301/01003Triacylglycerol lipase359
- C12Y 301/01004Phospholipase a2124
- C12Y 301/01001Carboxylesterase57
- C12Y 301/01074Cutinase49
- C12Y 301/01008Cholinesterase , i.e. butyrylcholine-esterase47
- C12Y 301/01032Phospholipase a147
- C12Y 301/01007Acetylcholinesterase44
- C12Y 301/01011Pectinesterase37
All 88 subgroupsShow fewer
- C12Y 301/01005Lysophospholipase32
- C12Y 301/01072Acetylxylan esterase27
- C12Y 301/01013Sterol esterase25
- C12Y 301/01073Feruloyl esterase25
- C12Y 301/01026Galactolipase21
- C12Y 301/0102Tannase18
- C12Y 301/01002Arylesterase16
- C12Y 301/010316-phosphogluconolactonase12
- C12Y 301/01034Lipoprotein lipase12
- C12Y 301/01006Acetylesterase11
- C12Y 301/010251,4-lactonase11
- C12Y 301/01064Retinoid isomerohydrolase11
- C12Y 301/01084Cocaine esterase11
- C12Y 301/01017Gluconolactonase10
- C12Y 301/01075Poly depolymerase10
- C12Y 301/01014Chlorophyllase7
- C12Y 301/01048Fusarinine-c ornithinesterase7
- C12Y 301/01085Pimelyl-[acyl-carrier protein] methyl ester esterase7
- C12Y 301/010471-alkyl-2-acetylglycerophosphocholine esterase , i.e. platelet-activating factor acetylhydrolase6
- C12Y 301/01068Xylono-1,4-lactonase6
- C12Y 301/010572-pyrone-4,6-dicarboxylate lactonase5
- C12Y 301/01023Acylglycerol lipase4
- C12Y 301/0105Wax-ester hydrolase4
- C12Y 301/01053Sialate o-acetylesterase4
- C12Y 301/01067Fatty-acyl-ethyl-ester synthase3
- C12Y 301/01081Quorum-quenching n-acyl-homoserine lactonase3
- C12Y 301/01089Protein phosphatase methylesterase-13
- C12Y 301/01019Uronolactonase2
- C12Y 301/01021Retinyl-palmitate esterase2
- C12Y 301/010243-oxoadipate enol-lactonase2
- C12Y 301/01028Acylcarnitine hydrolase2
- C12Y 301/01058N-acetylgalactosaminoglycan deacetylase2
- C12Y 301/01076Poly depolymerase2
- C12Y 301/01077Acyloxyacyl hydrolase2
- C12Y 301/01087Fumonisin b1 esterase2
- C12Y 301/01042Chlorogenate hydrolase1
- C12Y 301/01061Protein-glutamate methylesterase1
- C12Y 301/01086Rhamnogalacturonan acetylesterase1
- C12Y 301/01093Mycophenolic acid acyl-glucuronide esterase1
- C12Y 301/0101Tropinesterase0
- C12Y 301/01015L-arabinonolactonase0
- C12Y 301/010164-carboxymethyl-4-hydroxyisocrotonolactonase0
- C12Y 301/01022Hydroxybutyrate-dimer hydrolase0
- C12Y 301/010274-pyridoxolactonase0
- C12Y 301/01029Aminoacyl-trna hydrolase0
- C12Y 301/0103D-arabinonolactonase0
- C12Y 301/010336-acetylglucose deacetylase0
- C12Y 301/01035Dihydrocoumarin hydrolase0
- C12Y 301/01036Limonin-d-ring-lactonase0
- C12Y 301/01037Steroid-lactonase0
- C12Y 301/01038Triacetate-lactonase0
- C12Y 301/01039Actinomycin lactonase0
- C12Y 301/0104Orsellinate-depside hydrolase0
- C12Y 301/01041Cephalosporin-c deacetylase0
- C12Y 301/01043Alpha-amino-acid esterase0
- C12Y 301/010444-methyloxaloacetate esterase0
- C12Y 301/01045Carboxymethylenebutenolidase0
- C12Y 301/01046Deoxylimonate a-ring-lactonase0
- C12Y 301/01049Sinapine esterase0
- C12Y 301/01051Phorbol-diester hydrolase0
- C12Y 301/01052Phosphatidylinositol deacylase0
- C12Y 301/01054Acetoxybutynylbithiophene deacetylase0
- C12Y 301/01055Acetylsalicylate deacetylase0
- C12Y 301/01056Methylumbelliferyl-acetate deacetylase0
- C12Y 301/01059Juvenile-hormone esterase0
- C12Y 301/0106Bisphthalate esterase0
- C12Y 301/0106311-cis-retinyl-palmitate hydrolase0
- C12Y 301/01065L-rhamnono-1,4-lactonase0
- C12Y 301/010665--2,2'-bithiophene deacetylase0
- C12Y 301/0107Cetraxate benzylesterase0
- C12Y 301/01071Acetylalkylglycerol acetylhydrolase0
- C12Y 301/01078Polyneuridine-aldehyde esterase0
- C12Y 301/01079Hormone-sensitive lipase0
- C12Y 301/0108Acetylajmaline esterase0
- C12Y 301/01082Pheophorbidase0
- C12Y 301/01083Monoterpene epsilon-lactone hydrolase0
- C12Y 301/01088Pyrethroid hydrolase0
- C12Y 301/0109All-trans-retinyl ester 13-cis isomerohydrolase0
- C12Y 301/010912-oxo-3-propanoate lactonase0
- C12Y 301/010924-sulfomuconolactone hydrolase0
Recent patents
- Polypeptide variants29 Sep 2026US RE51,046 E1Novozymes A/S
- Millet and food products with reduced lipase activity, genes and implementation thereof15 Sep 2026US 12,733,662 B2
- Bacillus cell with reduced lipase and/or esterase side activities8 Sep 2026US 12,729,391 B2BASF SE
- Method for preparation of glycolipid carboxylic acids18 Aug 2026US 12,709,766 B2Anthem Biosciences Private Limited
- Degradable bio-based polymers11 Aug 2026US 12,703,768 B2Algenesis Corporation
- Enzymatic modification of galactolipids in food8 Oct 2026US 2026/0305624 A1International N&H Denmark Aps
- Gene therapy for lysosomal acid lipase deficiency (lal-d)8 Oct 2026US 2026/0308547 A1Research Institute At Nation Wide Children's Hospital
- Lipase Variants and Polynucleotides Encoding Same8 Oct 2026US 2026/0308548 A1Novozymes A/S
- Risankizumab compositions1 Oct 2026US 2026/0297178 A1AbbVie Inc.
- Process for degumming feedstock comprising brassica carinata oil1 Oct 2026US 2026/0297454 A1Dsm IP Assets B.V.
Most cited
By later US patents
- Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof118US 7,456,154 B2Yissum Research Development Company of the Hebrew University of Jerusalem · 2008
- Pharmaceutical compositions containing giroxina and phospholipase A.sub.2 and methods of increasing a patient's CD.sub.4 count using the pharmaceutical compositions117US 5,676,974 A1997
- Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them116US 5,891,725 AYissum Research Development Co. of the Hebrew Univ. of Jerusalem · 1999
- Oligonucleotide therapies for modulating the effects of herpes viruses91US 5,514,577 AIsis Pharmaceuticals, Inc. · 1996
- Stabilized protein crystals formulations containing them and methods of making them90US 6,541,606 B2Altus Biologics Inc. · 2003